Tucker John H 4
4 · scPharmaceuticals Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Tucker John H
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2025-01-03$3.56/sh−13,360$47,544→ 240,847 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on August 20, 2024 to satisfy tax withholding obligations of the Reporting Person related to the vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.48 to $3.62, inclusive. The reporting person undertakes to provide to scPharmaceuticals Inc., any security holder of scPharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this Form 4.